UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q/A

(Amendment No. 1)

 

(Mark One)

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2005

 

OR

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the transition period from                               to                               

 

Commission File Number 000-30637

 

 

AUGUST TECHNOLOGY CORPORATION

(Exact name of Registrant as specified in its charter)

 

Minnesota

 

41-1729485

(State of incorporation)

 

(I.R.S. Employer
Identification No.)

 

 

 

4900 West 78th Street

 

 

Bloomington, MN

 

55435

(Address of principal executive offices)

 

(Zip Code)

 

 

 

(952) 820-0080

(Registrant’s telephone number, including area code)

 

 

 

N/A

(Former name, former address, and former fiscal year, if changed since last report.)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ý   No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined by Exchange Act Rule 12b-2).  Yes  ý  No  o

 

As of July 31, 2005, there were 18,122,976 shares of common stock outstanding.

 

 



 

AUGUST TECHNOLOGY CORPORATION

EXPLANATORY NOTE

 

As previously disclosed, August Technology Corporation (the “Company”) has restated its consolidated financial statements for the year 2004 and for the first two quarters of 2005. The determination to restate these financial statements was made as a result of a correction of the Company’s application of revenue recognition principles contained in the Financial Accounting Standard Board’s Emerging Issues Task Force Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”).  As a result of subsequently reviewing our revenue recognition policies and procedures, we additionally noted that beginning in the fourth quarter of 2002 certain deferred software revenue should have been fully recognized upon delivery or customer acceptance rather than ratably over a twelve-month period.  As a result, the Company has restated its consolidated financial statements for the years 2004, 2003 and 2002 and for the first two quarters of 2005 (the “Restatement”).  Our restated consolidated financial statements also include disclosure of restated unaudited quarterly results for 2004 and 2003.  The Audit Committee of the Company’s Board of Directors (the “Audit Committee”) worked closely with the Company’s management to review the Restatement and the Company’s policies and practices for the recognition of revenue.  Further information on the adjustments can be found in Note 2, “Restatement of Financial Statements” to the accompanying consolidated financial statements.

 

This Amendment No. 1 on Form 10-Q/A (the “Form 10-Q/A”) to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2005, initially filed with the Securities and Exchange Commission (the “SEC”) on August 5, 2005 (the “Original Filing”), is being filed to reflect restatements of the Company’s consolidated balance sheet as of June 30, 2005, the Company’s consolidated statements of cash flows for the six-month periods ended June 30, 2005 and 2004, and the Company’s consolidated statements of operations for the three-month and six-month periods ended June 30, 2005 and June 30, 2004 and the notes related thereto.  Certain adjustments were recorded to each quarter in 2004 and the first two quarters of 2005 to correct other miscellaneous items identified in prior external audits or quarterly reviews but were previously passed, none of which were individually significant.  For a more detailed description of the restatement, see Note 2, “Restatement of Financial Statements” to the accompanying consolidated financial statements and the section entitled “Restatement” in Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this Form 10-Q/A.

 

Concurrent with the filing of this Form 10-Q/A we are filing an Amendment No. 1 on Form 10-K/A (the “Form 10-K/A”) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2004 to reflect restatements of the Company’s consolidated balance sheets as of December 31, 2004 and 2003 and the Company’s consolidated statements of operations, cash flows and stockholders’ equity for the years ended December 31, 2004, 2003 and 2002 and the notes related thereto.

 

For the convenience of the reader, this Form 10-Q/A sets forth the Original Filing in its entirety. However, this Form 10-Q/A only amends and restates Items 1, 2 and 4 of Part I of the Original Filing, in each case, solely as a result of, and to reflect, the Restatement, and no other information in the Original Filing is amended hereby. The foregoing items have not been updated to reflect other events occurring after the Original Filing or to modify or update those disclosures affected by subsequent events. In addition, pursuant to the rules of the SEC, Item 6 of Part II of the Original Filing has been amended to contain currently-dated certifications from the Company’s Chief Executive Officer and Chief Financial Officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The certifications of the Company’s Chief Executive Officer and Chief Financial Officer are attached to this Form 10-Q/A as Exhibits 31.1, 31.2 and 32.1.

 

Except for the foregoing amended information, this Form 10-Q/A continues to speak as of the date of the Original Filing, and the Company has not updated the disclosures contained herein to reflect events that occurred at a later date.  Other events occurring after the filing of the Original Filing or other disclosures

 

2



 

necessary to reflect subsequent events have been or will be addressed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2005 which is being filed concurrently with the filing of this Form 10-Q/A, and any reports filed with the SEC subsequent to the date of this filing.

 

The Company has not amended and does not intend to amend its previously filed Quarterly Reports on Form 10-Q for the periods affected by the Restatement prior to December 31, 2004. For this reason, the consolidated financial statements and related financial information for the affected periods contained in such reports should no longer be relied upon.

 

3



 

AUGUST TECHNOLOGY CORPORATION

 

TABLE OF CONTENTS

 

 

Description

 

 

 

PART I

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements (unaudited)

 

 

 

 

Consolidated Balance Sheets as of June 30, 2005 and December 31, 2004

 

 

 

 

 

Consolidated Statements of Operations for the three and six months ended June 30, 2005 and 2004

 

 

 

 

 

Consolidated Statements of Cash Flows for the six months ended June 30, 2005 and 2004

 

 

 

 

 

Notes to Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

PART II

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

 

 

 

 

 

Item 6.

Exhibits

 

 

 

 

SIGNATURES

 

 

 

 

EXHIBIT INDEX

 

 

4



 

PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements

AUGUST TECHNOLOGY CORPORATION

 

CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

(Unaudited)

 

 

 

June 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

10,313

 

$

5,518

 

Short-term marketable debt securities

 

22,583

 

28,615

 

Accounts receivable, net

 

10,389

 

8,328

 

Inventories

 

21,393

 

20,106

 

Inventories at customers under purchase orders

 

9,294

 

6,704

 

Prepaid expenses and other current assets

 

1,951

 

2,517

 

Total current assets

 

75,923

 

71,788

 

 

 

 

 

 

 

Property and equipment, net

 

5,342

 

5,994

 

Long-term marketable debt securities

 

9,034

 

16,289

 

Purchased technology, net

 

3,098

 

3,703

 

Goodwill

 

498

 

498

 

Other assets

 

162

 

150

 

Total assets

 

$

94,057

 

$

98,422

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

6,747

 

$

3,291

 

Accrued compensation

 

2,952

 

1,636

 

Other accrued liabilities

 

2,294

 

2,322

 

Customer deposits and deferred revenues

 

17,051

 

11,973

 

Total current liabilities

 

29,044

 

19,222

 

 

 

 

 

 

 

Other non-current liabilities

 

108

 

131

 

Total liabilities

 

29,152

 

19,353

 

 

 

 

 

 

 

Commitments and contingencies (note 9)

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Common stock, no par value, 42,000,000 shares authorized, 18,064,032 and 17,839,298 shares issued and outstanding, respectively

 

91,447

 

90,363

 

Undesignated capital stock, no par value, 3,000,000 shares authorized, no shares issued or outstanding

 

 

 

Accumulated deficit

 

(26,446

)

(11,188

)

Accumulated other comprehensive loss

 

(96

)

(106

)

Total shareholders’ equity

 

64,905

 

79,069

 

Total liabilities and shareholders’ equity

 

$

94,057

 

$

98,422

 

 

See accompanying notes to consolidated financial statements.

 

5



 

AUGUST TECHNOLOGY CORPORATION

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

16,749

 

$

18,024

 

$

31,785

 

$

34,869

 

Cost of revenues

 

6,953

 

8,159

 

13,777

 

15,217

 

Gross profit

 

9,796

 

9,865

 

18,008

 

19,652

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

7,236

 

5,390

 

13,574

 

10,579

 

Research and development expenses

 

3,324

 

3,322

 

6,990

 

6,230

 

Operating income (loss)

 

(764

)

1,153

 

(2,556

)

2,843

 

 

 

 

 

 

 

 

 

 

 

Merger expenses

 

(11,991

)

 

(13,225

)

 

Interest income

 

334

 

189

 

623

 

390

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before provision for income taxes

 

(12,421

)

1,342

 

(15,158

)

3,233

 

Provision for income taxes

 

50

 

59

 

100

 

100

 

Net income (loss)

 

$

(12,471

)

$

1,283

 

$

(15,258

)

$

3,133

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.69

)

$

0.07

 

$

(0.85

)

$

0.18

 

Diluted

 

$

(0.69

)

$

0.07

 

$

(0.85

)

$

0.17

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

18,005

 

17,778

 

17,936

 

17,700

 

Diluted

 

18,005

 

18,349

 

17,936

 

18,421

 

 

See accompanying notes to consolidated financial statements.

 

6



 

AUGUST TECHNOLOGY CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

 

$

(15,258

)

$

3,133

 

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

2,115

 

1,019

 

Provision for (recovery of) doubtful accounts

 

(57

)

79

 

Tax benefit from employee stock options

 

13

 

 

Deferred income taxes

 

6

 

 

Stock based compensation

 

30

 

 

Amortization of deferred compensation related to stock options

 

 

27

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(1,998

)

(8,874

)

Inventories

 

(1,142

)

(7,048

)

Inventories at customers under purchase orders

 

(2,590

)

(3,679

)

Prepaid expenses and other current assets

 

575

 

(402

)

Accounts payable

 

3,456

 

2,120

 

Accrued compensation

 

1,312

 

696

 

Accrued liabilities

 

 

9

 

Customer deposits and deferred revenues

 

5,076

 

2,202

 

Net cash used in operating activities

 

(8,462

)

(10,718

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Proceeds from maturities of marketable debt securities

 

45,389

 

94,356

 

Purchases of marketable debt securities

 

(32,119

)

(91,499

)

Purchases of property and equipment

 

(843

)

(2,455

)

Investment in other assets

 

(186

)

(77

)

Cash paid for acquisitions

 

(28

)

(17

)

Proceeds from disposition of property and equipment

 

4

 

 

Net cash provided by investing activities

 

12,217

 

308

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Net proceeds from issuances of common stock to employees

 

1,161

 

1,988

 

Redemption of common stock

 

(120

)

 

Net cash provided by financing activities

 

1,041

 

1,988

 

 

 

 

 

 

 

Effect of exchange rates on cash and cash equivalents

 

(1

)

(13

)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

4,795

 

(8,435

)

Cash and cash equivalents at beginning of period

 

5,518

 

10,027

 

Cash and cash equivalents at end of period

 

$

10,313

 

$

1,592

 

 

 

 

 

 

 

Supplemental cash flow information:

 

 

 

 

 

Cash payments of income taxes

 

$

(209

)

$

(78

)

Cash payments for merger expenses

 

$

(12,342

)

$

 

 

See accompanying notes to consolidated financial statements.

 

7



 

AUGUST TECHNOLOGY CORPORATION

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2005

(In thousands, except per share amounts)

(Unaudited)

 

Note 1 – Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures, normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted pursuant to such rules and regulations.  In the opinion of the management of August Technology Corporation (collectively with its subsidiaries, the “Company”), all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included in the consolidated balance sheet at June 30, 2005, the consolidated statements of operations for the three and six months ended June 30, 2005 and 2004, and the consolidated statements of cash flows for the six months ended June 30, 2005 and 2004.  The statements of operations of the interim periods are not necessarily indicative of the results of operations that may be expected for any other period or for the year as a whole.  These consolidated financial statements and notes hereto should be read in conjunction with the audited restated consolidated financial statements and notes thereto included in the Company’s Amendment No. 1 on Form 10-K/A for the year ended December 31, 2004, which is being filed with the Securities and Exchange Commission concurrently with the filing of this Form 10-Q/A .

 

The accompanying consolidated financial statements include the accounts of August Technology Corporation and its wholly owned subsidiaries.  All significant intercompany balances and transactions are eliminated in consolidation.

 

Management uses estimates and assumptions in preparing consolidated financial statements in accordance with accounting principles generally accepted in the United States of America.  Those estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported revenues and expenses during the reporting periods.  Actual results could differ from those estimates.

 

Note 2 – Restatement of Financial Statements

 

We have restated our consolidated financial statements for the years 2004, 2003 and 2002 and for the first two quarters of 2005.  In addition, certain disclosures in Notes 4, 6, 7, 10, 12 and 13 to the consolidated financial statements contained in this report have been restated to reflect the Restatement adjustments.  Our restated consolidated financial statements also include disclosure of restated unaudited quarterly results for 2004 and 2003.  The initial determination to restate the 2004 and first half 2005 consolidated financial statements was made as a result of a correction of the Company’s application of revenue recognition principles, as contained in the Financial Accounting Standard Board’s Emerging Issues Task Force Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”).  As a result of subsequently reviewing our revenue recognition policies and procedures, we additionally noted that beginning in the fourth quarter of 2002 certain deferred software revenue should have been fully recognized upon delivery or customer acceptance rather than ratably over a twelve-month period. This created the need to restate our 2002 and 2003 consolidated financial statements.  Certain adjustments were recorded to each quarter in 2004 and first two quarters of 2005 to correct other miscellaneous items identified in prior external audits or quarterly reviews but were previously passed, none of which were individually significant.

 

8



 

In 2004 and the first half of 2005, the Company sold AXi 930 systems to a customer for an aggregate amount of approximately $12.2 million ($6.7 million in 2004, $3.1 million in the first quarter of 2005 and $2.4 million in the second quarter of 2005) and recognized the revenue for these sales.  The cost of revenues related to these sales was $2.7 million in 2004, $1.5 million in the first quarter of 2005 and $1.2 million in the second quarter of 2005.  For the three and six months ended June 30, 2004, the Company originally recognized $2.2 million in revenue and $0.9 million in cost of revenue for these AXi 930 sales.  During the same time periods, the Company accepted orders from the same customer for enhancement packages to the AXi 930 system but had not yet delivered the enhancement packages.  In connection with preparing to finalize its results for the quarter ended September 30, 2005, the Company determined that recognition of the $12.2 million of revenue from the AXi 930 systems should have been deferred until the delivery of the enhancement packages, according to EITF 00-21.  The customer cancelled its orders for the enhancement packages on September 27, 2005, which allowed the Company to recognize the entire $12.2 million of AXi 930 deferred revenue in the quarter ended September 30, 2005.

 

In the fourth quarter of 2002, the Company began deferring Yield Pilot software revenue and recognizing it over a twelve-month period which represented the Company’s obligation to provide warranty and support.  The Company determined based on a subsequent review of Statement of Position 97-2, “Software Revenue Recognition” that Yield Pilot software revenues should have been recognized upon delivery or customer acceptance.  The correction of this error had no significant impact on revenues for the three months ended June 30, 2005 and decreased revenue by $0.3 million for the three months ended March 31, 2005. The correction increased revenue by $0.4 million for each of the first two quarters in 2004 and had no impact on cost of revenues.  The correction increased revenue by $0.9 million, $0.5 million and $0.2 million for 2004, 2003 and 2002, respectively and had no impact on costs of revenues.

 

In the second quarter of 2005, the Company recognized $0.6 million in revenue and $0.2 million in cost of revenue related to the sale of an NSX 105 inspection system.  It was subsequently determined that this revenue should have been deferred until the newly introduced software component of this bundled transaction was completed and delivered.  This error was corrected as part of the restatement of the second quarter of 2005.  The Company expects to realize revenue on the completed transaction in the fourth quarter of 2005 when all elements will be delivered and accepted and fair value has been established for the newly introduced software component.

 

The impact of the Restatement on the consolidated statements of operations for the three-month and six-month periods ended June 30, 2005 and 2004 is shown in the accompanying tables.  The primary impact of the Restatement on the consolidated balance sheet at June 30, 2005 was to increase inventory at customers under purchase orders related to the deferral of the cost of revenue and to increase customer deposits and deferred revenues related to cash collected for revenue deferred in the Restatement.  The Restatement had no impact on cash balances or net cash flows from operating, investing, or financing activities.  The impact of the Restatement on the consolidated balance sheet and consolidated statements of cash flows is shown in the accompanying tables.

 

9



 

The following table presents the effect of the Restatement on the consolidated balance sheet:

 

 

 

June 30, 2005

 

 

 

As

 

 

 

 

 

 

 

Previously

 

 

 

As

 

 

 

Reported

 

Adjustments

 

Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

10,313

 

$

 

$

10,313

 

Short-term marketable debt securities

 

22,583

 

 

22,583

 

Accounts receivable, net

 

12,035

 

(1,646

)

10,389

 

Inventories

 

21,393

 

 

21,393

 

Inventories at customers under purchase orders

 

3,646

 

5,648

 

9,294

 

Prepaid expenses and other current assets

 

1,651

 

300

 

1,951

 

Total current assets

 

71,621

 

4,302

 

75,923

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

5,342

 

 

5,342

 

Long-term marketable debt securities

 

9,034

 

 

9,034

 

Purchased technology, net

 

3,098

 

 

3,098

 

Goodwill

 

498

 

 

498

 

Other assets

 

162

 

 

162

 

Total assets

 

$

89,755

 

$

4,302

 

$

94,057

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

6,947

 

$

(200

)

$

6,747

 

Accrued compensation

 

2,952

 

 

2,952

 

Other accrued liabilities

 

2,353

 

(59

)

2,294

 

Customer deposits and deferred revenues

 

6,769

 

10,282

 

17,051

 

Total current liabilities

 

19,021

 

10,023

 

29,044

 

 

 

 

 

 

 

 

 

Other non-current liabilities

 

108

 

 

108

 

Total liabilities

 

19,129

 

10,023

 

29,152

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

Common stock, no par value

 

91,437

 

10

 

91,447

 

Undesignated capital stock, no par value

 

 

 

 

Accumulated deficit

 

(20,715

)

(5,731

)

(26,446

)

Accumulated other comprehensive loss

 

(96

)

 

(96

)

Total shareholders’ equity

 

70,626

 

(5,721

)

64,905

 

Total liabilities and shareholders’ equity

 

$

89,755

 

$

4,302

 

$

94,057

 

 

10



 

The following table presents the effect of the Restatement on the consolidated statements of operations:

 

 

 

Three Months Ended June 30, 2005

 

Three Months Ended June 30, 2004

 

 

 

As
Previously
Reported

 

Adjustments

 

As
Restated

 

As
Previously
Reported

 

Adjustments

 

As
Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

19,688

 

$

(2,939

)

$

16,749

 

$

19,855

 

$

(1,831

)

$

18,024

 

Cost of revenues

 

8,403

 

(1,450

)

6,953

 

9,059

 

(900

)

8,159

 

Gross profit

 

11,285

 

(1,489

)

9,796

 

10,796

 

(931

)

9,865

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

7,237

 

(1

)

7,236

 

5,390

 

 

5,390

 

Research and development expenses

 

3,324

 

 

3,324

 

3,322

 

 

3,322

 

Operating income (loss)

 

724

 

(1,488

)

(764

)

2,084

 

(931

)

1,153

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merger expenses

 

(11,991

)

 

(11,991

)

 

 

 

Interest income

 

335

 

(1

)

334

 

189

 

 

189

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before provision for income taxes

 

(10,932

)

(1,489

)

(12,421

)

2,273

 

(931

)

1,342

 

Provision for income taxes

 

109

 

(59

)

50

 

100

 

(41

)

59

 

Net income (loss)

 

$

(11,041

)

$

(1,430

)

$

(12,471

)

$

2,173

 

$

(890

)

$

1,283

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.61

)

(0.08

)

$

(0.69

)

$

0.12

 

(0.05

)

$

0.07

 

Diluted

 

$

(0.61

)

(0.08

)

$

(0.69

)

$

0.12

 

(0.05

)

$

0.07

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding used to calculate net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

18,005

 

 

 

18,005

 

17,778

 

 

 

17,778

 

Diluted

 

18,005

 

 

 

18,005

 

18,349

 

 

 

18,349

 

 

11



 

The following table presents the effect of the Restatement on the consolidated statements of operations:

 

 

 

Six Months Ended June 30, 2005

 

Six Months Ended June 30, 2004

 

 

 

As

 

 

 

 

 

As

 

 

 

 

 

 

 

Previously

 

 

 

As

 

Previously

 

 

 

As

 

 

 

Reported

 

Adjustments

 

Restated

 

Reported

 

Adjustments

 

Restated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

38,105

 

$

(6,320

)

$

31,785

 

$

36,255

 

$

(1,386

)

$

34,869

 

Cost of revenues

 

16,762

 

(2,985

)

13,777

 

16,117

 

(900

)

15,217

 

Gross profit

 

21,343

 

(3,335

)

18,008

 

20,138

 

(486

)

19,652

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

13,526

 

48

 

13,574

 

10,579

 

 

10,579

 

Research and development expenses

 

6,990

 

 

6,990

 

6,230

 

 

6,230

 

Operating income (loss)

 

827

 

(3,383

)

(2,556

)

3,329

 

(486

)

2,843

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merger expenses

 

(13,225

)

 

(13,225

)

 

 

 

Interest income

 

623

 

 

623

 

390

 

 

390

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before provision for income taxes

 

(11,775

)

(3,383

)

(15,158

)

3,719

 

(486

)

3,233

 

Provision for income taxes

 

164

 

(64

)

100

 

100

 

 

100

 

Net income (loss)

 

$

(11,939

)

$

(3,319

)

$

(15,258

)

$

3,619

 

$

(486

)

$

3,133

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.67

)

(0.18

)

$

(0.85

)

$

0.20

 

(0.02

)

$

0.18

 

Diluted

 

$

(0.67

)

(0.18

)

$

(0.85

)

$

0.20

 

(0.03

)

$

0.17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding used to calculate net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

17,936

 

 

 

17,936

 

17,700

 

 

 

17,700

 

Diluted

 

17,936

 

 

 

17,936

 

18,421

 

 

 

18,421

 

 

12



 

The following table presents the effect of the Restatement on the consolidated statement of cash flows:

 

 

 

Six Months Ended June 30, 2005

 

 

 

As Previously

 

 

 

As

 

 

 

Reported

 

Adjustments

 

Restated

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net loss

 

$

(11,939

)

$

(3,319

)

$

(15,258

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

2,115

 

 

2,115

 

Recovery of doubtful accounts

 

(57

)

 

(57

)

Tax benefit from stock options exercised

 

19

 

(6

)

13

 

Deferred income taxes

 

6

 

 

6

 

Stock based compensation

 

30

 

 

 

30

 

Changes in operating assets and liabilities, net of effect of acquisitions:

 

 

 

 

 

 

 

Accounts receivable

 

(3,369

)

1,371

 

(1,998

)

Inventories

 

(1,117

)

(25

)

(1,142

)

Inventories at customers under purchase orders

 

347

 

(2,937

)

(2,590

)

Prepaid expenses and other current assets

 

664

 

(89

)

575

 

Accounts payable

 

3,581

 

(125

)

3,456

 

Accrued compensation

 

1,257

 

55

 

1,312

 

Other accrued liabilities

 

73

 

(73

)

 

Customer deposits and deferred revenues

 

(72

)

5,148

 

5,076

 

Net cash used in operating activities

 

(8,462

)

 

(8,462

)

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Proceeds from maturities of marketable debt securities

 

45,389

 

 

45,389

 

Purchases of marketable debt securities

 

(32,119

)

 

(32,119

)

Purchases of property and equipment

 

(843

)

 

(843

)

Investments in other assets

 

(186

)

 

(186

)

Proceeds from disposition of property and equipment

 

4

 

 

4

 

Cash paid for acquistions

 

(28

)

 

(28

)

Net cash provided by investing activities

 

12,217

 

 

12,217

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Net proceeds from issuances of common stock

 

1,161

 

 

1,161

 

Redemption of common stock

 

(120

)

 

(120

)

Net cash provided by financing activities

 

1,041

 

 

1,041

 

 

 

 

 

 

 

 

 

Effect of exchange rates on cash and cash equivalents

 

(1

)

 

(1

)

Net increase in cash and cash equivalents

 

4,795

 

 

4,795

 

Cash and cash equivalents at beginning of year

 

5,518

 

 

5,518

 

Cash and cash equivalents at end of year

 

$

10,313

 

$

 

$

10,313

 

 

13



 

 

 

Six Months Ended June 30, 2004

 

 

 

As

 

 

 

 

 

 

 

Previously

 

 

 

As

 

 

 

Reported

 

Adjustments

 

Restated

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income

 

$

3,619

 

$

(486

)

$

3,133

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

1,019

 

 

1,019

 

Provision for doubtful accounts

 

79

 

 

79

 

Stock based compensation

 

27

 

 

27

 

Changes in operating assets and liabilities, net of effect of acquisitions:

 

 

 

 

 

 

 

Accounts receivable

 

(11,185

)

2,311

 

(8,874

)

Inventories

 

(7,048

)

 

(7,048

)

Inventories at customers under purchase orders

 

(2,779

)

(900

)

(3,679

)

Prepaid expenses and other current assets

 

(402

)

 

(402

)

Accounts payable

 

2,220

 

(100

)

2,120

 

Accrued compensation

 

696

 

 

696

 

Other accrued liabilities

 

9

 

 

9

 

Customer deposits and deferred revenues

 

3,027

 

(825

)

2,202

 

Net cash used in operating activities

 

(10,718

)

 

(10,718

)

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Proceeds from maturities of marketable debt securities

 

94,356

 

 

94,356

 

Purchases of marketable debt securities

 

(91,499

)

 

(91,499

)

Purchases of property and equipment

 

(2,455

)

 

(2,455

)

Investments in other assets

 

(77

)

 

(77

)

Cash paid for acquisitions

 

(17

)

 

(17

)

Net cash provided by investing activities

 

308

 

 

308

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Net proceeds from issuances of common stock

 

1,988

 

 

1,988

 

Net cash provided by financing activities

 

1,988

 

 

1,988

 

 

 

 

 

 

 

 

 

Effect of exchange rates on cash and cash equivalents

 

(13

)

 

(13

)

Net decrease in cash and cash equivalents

 

(8,435

)

 

(8,435

)

Cash and cash equivalents at beginning of year

 

10,027

 

 

10,027

 

Cash and cash equivalents at end of year

 

$

1,592

 

$

 

$

1,592

 

 

 

14



 

Note 3 – Business Combinations

 

On January 21, 2005, the Company entered into an Agreement and Plan of Merger and Reorganization (the “Nanometrics Merger Agreement”) with Nanometrics, Incorporated (“Nanometrics”), Major League Merger Corporation and Minor League Merger Corporation.    Under the terms of the Nanometrics Merger Agreement each share of the Company’s common stock was to be converted into the right to receive 0.6401 of a share of August Nanometrics common stock.  On June 27, 2005, the Company and Nanometrics terminated the Nanometrics Merger Agreement.  In accordance with the terms of the Nanometrics Merger Agreement, the Company paid Nanometrics a termination fee of $8,300, and reimbursed $2,600 of merger related expenses.

 

On June 27, 2005, the Company entered into an Agreement and Plan of Merger (the “Rudolph Merger Agreement”) with Rudolph Technologies, Inc. (“Rudolph”) and NS Merger Sub, Inc.  Under the terms of the Rudolph Merger Agreement each of the Company’s shareholders will have the option to elect to receive either $10.50 per share in cash or 0.7625 of a share of Rudolph common stock, subject to proration and allocation, based on the total cash and shares available in the merger. The agreement requires that the total consideration for the transaction will include a minimum of $37,200 and a maximum of $60,000 of cash subject to shareholder election.  The aggregate consideration was approximately $193,000 as of June 27, 2005.

 

Note 4 – Stock-Based Compensation

 

The Company applies Accounting Principles Board Opinion (“APB”) No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for stock-based compensation.  The exercise price of the Company’s stock options equals the market price of the underlying stock on the date of grant for all options granted, and thus, under APB 25, no compensation expense is recognized in the consolidated statements of operations.

 

The estimated per share weighted average fair value of all stock options granted during the three months ended June 30, 2005 and 2004 was $7.15 and $9.53, respectively, and for the six months ended June 30, 2005 and 2004 was $6.78 and $9.91, respectively.  The fair value of each option grant was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

 

 

 

 

 

 

Expected life

 

4.9 years

 

5.5 years

 

4.7 years

 

4.3 years

 

Risk free interest rate

 

3.9

%

3.6

%

3.8

%

2.8

%

Volatility

 

72.5

%

73.7

%

73.3

%

74.1

%

Dividend yield

 

 

 

 

 

 

Had the Company recorded compensation cost based on the estimated fair value on the date of grant, as defined by Statement of Financial Accounting Standards (“SFAS”) 123, “Accounting for Stock-Based Compensation,” the Company’s pro forma net income (loss) would have been as follows:

 

15



 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss), as reported

 

$

(12,471

)

1,283

 

(15,258

)

3,133

 

 

 

 

 

 

 

 

 

 

 

Add:

 

 

 

 

 

 

 

 

 

Stock-based employee compensation expense included in net income (loss), as reported

 

30

 

 

30

 

 

Deduct:

 

 

 

 

 

 

 

 

 

Stock-based employee compensation expense determined under fair value based method for all awards

 

(541

)

(521

)

(1,342

)

(1,674

)

Net income (loss), pro forma

 

$

(12,982

)

$

762

 

$

(16,570

)

$

1,459

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

As reported:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.69

)

0.07

 

(0.85

)

0.18

 

Diluted

 

$

(0.69

)

0.07

 

(0.85

)

0.17

 

 

 

 

 

 

 

 

 

 

 

Pro forma:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.72

)

0.04

 

(0.92

)

0.08

 

Diluted

 

$

(0.72

)

0.04

 

(0.92

)

0.08

 

 

On March 30, 2005, the board of directors authorized the Company to enter into an agreement to grant 175,000 nonqualified stock options to the Company’s President and Chief Operating Officer upon acceptance of the position.  The grant is not part of the Company’s 1997 Stock Incentive Plan, and was not approved by the Company’s shareholders.  The options were granted at fair market value on the date of grant, and vest ratably over five years from the date of grant.  In the event of a change in control, the board of directors may provide for the acceleration of vesting of the options.

 

Note 5 – Marketable Debt Securities

 

The amortized cost and estimated fair value of available-for-sale marketable debt securities were as follows:

 

 

 

June 30, 2005

 

 

 

 

 

Gross

 

Gross

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

 

 

Cost

 

Gains

 

Losses

 

Value

 

Corporate bonds

 

$

10,454

 

$

5

 

$

(57

)

$

10,402

 

Municipal bonds

 

21,287

 

1

 

(73

)

21,215

 

 

 

$

31,741

 

$

6

 

$

(130

)

$

31,617

 

 

 

 

December 31, 2004

 

 

 

 

 

Gross

 

Gross

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

 

 

Cost

 

Gains

 

Losses

 

Value

 

Corporate bonds

 

$

12,611

 

$

1

 

$

(55

)

$

12,557

 

Municipal bonds

 

32,400

 

3

 

(56

)

32,347

 

 

 

$

45,011

 

$

4

 

$

(111

)

$

44,904

 

 

16



 

The maturities of available-for-sale marketable debt securities were as follows:

 

 

 

June 30, 2005

 

December 31, 2004

 

 

 

Amortized

 

Fair

 

Amortized

 

Fair

 

 

 

Cost

 

Value

 

Cost

 

Value

 

Due within one year

 

$

22,652

 

$

22,583

 

$

28,662

 

$

28,615

 

Due after one year through three years

 

7,789

 

7,742

 

13,349

 

13,289

 

Due after three years

 

1,300

 

1,292

 

3,000

 

3,000

 

 

 

$

31,741

 

$

31,617

 

$

45,011

 

$

44,904

 

 

Net realized gains and losses were not material for the six months ended June 30, 2005 and 2004.

 

Note 6 – Accounts Receivable

 

Accounts receivable consisted of the following:

 

 

 

June 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

Billed receivables

 

$

9,264

 

$

7,994

 

Unbilled revenue

 

1,815

 

1,024

 

 

 

11,079

 

9,018

 

Allowance for doubtful accounts

 

(690

)

(690

)

Accounts receivable, net

 

$

10,389

 

$

8,328

 

 

Note 7 – Inventories

 

Inventories consisted of the following:

 

 

 

June 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

 

 

(Restated)

 

 

 

 

 

 

 

Raw materials

 

$

10,220

 

$

8,449

 

Work in process

 

4,065

 

3,558

 

Demonstration equipment

 

4,312

 

4,152

 

Finished goods

 

2,796

 

3,947

 

Inventories

 

$

21,393

 

$

20,106

 

 

Note 8 – Purchased Technology

 

Purchased technology was as follows:

 

 

 

June 30,

 

December 31,

 

 

 

2005

 

2004

 

Purchased technology

 

$

4,769

 

$

4,651

 

Less: accumulated amortization

 

(1,671

)

(948

)

Purchased technology, net

 

$

3,098

 

$

3,703

 

 

Purchased technology increased $118 for the six months ended June 30, 2005 due to contingent consideration paid for the DMSVision acquisition discussed in Note 9 below.  Amortization expense for the six months ended June 30, 2005 and 2004 was $724 and $174, respectively.  Assuming no additional change in the gross carrying value of purchased technology, the estimated amortization expense for the twelve months ending December 31, 2005 is $1,435 and for each of the next four years is $1,208, $800, $378 and none.

 

17



 

In December 2004, the Company purchased certain technology from Excelerate Technologies, Inc. (“Excelerate”).  The total consideration paid was $800, which included the forgiveness of a $500 convertible note receivable from Excelerate and $300 of cash, of which $150 was paid in January 2005.

 

Note 9 – Commitments and Contingencies

 

Warranties

 

The Company provides warranty coverage for its systems for a period of one year, including parts and labor necessary to repair the systems during the warranty period.  The estimated warranty cost is based on the Company’s historical experience rate of incurred expenses to corresponding system revenues.

 

The following table summarizes the activity related to the warranty liability during the six months ended June 30, 2005 and 2004:

 

 

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

Accrual at beginning of year

 

$

942

 

$

239

 

Warranties issued

 

395

 

415

 

Costs incurred

 

(188

)

(271

)

Accrual at end of period

 

$

1,149

 

$

383

 

 

Separation Agreements

 

In the second quarter of 2005, the Company entered into separation agreements with certain executives and other employees that resulted in an expense of $920, of which $29 was paid as of June 30, 2005.  The separation agreements require substantially all of the severance benefits to be paid by June 30, 2006.

 

Contingent Consideration

 

In connection with the July 27, 2004 acquisition of the DMSVision software division of Inspex, Inc (“DMSVision”), the Company is subject to a contingent consideration arrangement at June 30, 2005.  This arrangement is based upon new orders for DMSVision software licenses received in the twelve months after the acquisition.  The payment of the contingency results in an increase in the allocation of purchase price to purchased technology.  As a result, amortization expense related to this asset increases.  Amounts paid under this arrangement are not expected to have a material effect on the Company’s consolidated financial condition or results of operations.  The total contingent consideration the Company expects to pay related to the twelve months after the acquisition is $142, of which $24 and $118 was added to purchased technology in 2004 and 2005, respectively.  As of June 30, 2005, $90 remained unpaid.

 

Legal Proceedings

 

From time to time in the ordinary course of business, the Company is subject to claims, asserted or unasserted, or named as a party to lawsuits or investigations.  Litigation, in general, and intellectual property and securities litigation in particular, can be expensive and disruptive to normal business operations.  Moreover, the results of legal proceedings cannot be predicted with any certainty and in the case of more complex legal proceedings such as intellectual property and securities litigation, the results are difficult to predict at all.

 

The Company and each of its board of directors, Jeff O’Dell, James Bernards, Roger Gower, Michael Wright and Linda Hall Whitman, were named as defendants in two separate lawsuits that purported to be class

 

18



 

action claims on behalf of the Company’s shareholders.  The Company received a summons and complaint with respect to the first of these proceedings on February 4, 2005 and the second on February 14, 2005.  Both lawsuits were brought in Minnesota State Court and claimed that the directors had breached their fiduciary duties to the Company’s shareholders in connection with their actions in agreeing to the proposed merger with Nanometrics Incorporated.  The plaintiffs in both actions sought various forms of injunctive relief including an order enjoining the Company and its board of directors from consummating the merger with Nanometrics.

 

The two proceedings were consolidated and heard as one case.  On April 19, 2005, the Court issued a 30 day stay of all proceedings.  On April 27, 2005, the plaintiffs scheduled a hearing on a motion to amend the complaint.  The hearing was scheduled for June 9, 2005.  On May 10, 2005 the Court issued an order dismissing the complaint for asserting derivative claims without complying with the rules governing derivative actions.  Thereafter the Court removed the hearing from the calendar.

 

On July 18, 2005, a purported shareholder class action lawsuit asserting derivative claims was filed in Minnesota state court against the Company and the individual members of the board named above as well as Lynn J. Davis, who joined the board on March 30, 2005 (the “Board”).  The lawsuit claims the directors have breached their fiduciary duties to the Company’s shareholders in connection with their actions in approving the merger agreement with Nanometrics, Inc. and subsequently terminating that merger agreement and entering into a new merger agreement with Rudolph Technologies, Inc.  The plaintiff seeks various forms of injunctive relief including an order enjoining the Company and the Board from consummating the proposed merger with Rudolph.

 

The plaintiff in the lawsuit filed on July 18, 2005 is Robert Etem, the owner of 4,200 shares of the Company’s common stock.  Mr. Etem was also a plaintiff in the lawsuit described above filed on February 14, 2005.

 

On July 14, 2005, the Company filed a patent infringement lawsuit against Camtek, Ltd. of Migdal Haemek, Israel.  The patent infringement lawsuit, filed in U.S. federal court in Minneapolis, alleges that Camtek’s line of inspection equipment sold under the “Falcon” trademark infringes on the Company’s U.S. patent no. 6,826,298.

 

19



 

Note 10 – Net Income (Loss) Per Share

 

The components of basic and diluted net income (loss) per share were as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(12,471

)

$

1,283

 

$

(15,258

)

$

3,133

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares:

 

 

 

 

 

 

 

 

 

Basic

 

18,005

 

17,778

 

17,936

 

17,700

 

Effect of dilutive stock options and warrants

 

 

571

 

 

721

 

Diluted

 

18,005

 

18,349

 

17,936

 

18,421

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.69

)

$

0.07

 

$

(0.85

)

$

0.18

 

Diluted

 

$

(0.69

)

$

0.07

 

$

(0.85

)

$

0.17

 

 

The total weighted average number of stock options and warrants excluded from the calculation of potentially dilutive securities either due to the exercise price exceeding the average market price or the inclusion of such securities in a calculation of net income (loss) per share would have been anti-dilutive for the three months ended June 30, 2005 and 2004 were 2,106 and 330, respectively, and for the six months ended June 30, 2005 and 2004 were 2,053 and 218, respectively.

 

Note 11 – Accumulated Other Comprehensive Loss

 

The accumulated balances for each classification of accumulated other comprehensive loss are as follows:

 

 

 

June 30,

 

December 31,

 

 

 

2005

 

2004

 

 

 

 

 

 

 

Currency translation adjustments

 

$

28

 

$

1

 

Net unrealized losses on marketable debt securities

 

(124

)

(107

)

Accumulated other comprehensive loss

 

$

(96

)

$

(106

)

 

20


 


 

Note 12 – Shareholders’ Equity

 

Changes in shareholders’ equity during the six months ended June 30, 2005 were as follows:

 

Shareholders’ equity balance at December 31, 2004 (Restated)

 

$

79,069

 

Net loss (Restated)

 

(15,258

)

Accumulated other comprehensive loss:

 

 

 

Foreign currency translation adjustment

 

27

 

Net unrealized loss on marketable debt securities

 

(17

)

Comprehensive loss (Restated)

 

(15,248

)

Issuances of common stock in conjunction with:

 

 

 

Exercises of employee stock options

 

1,038

 

Employee stock purchase plan

 

123

 

Redemption of common stock

 

(120

)

Tax benefit from stock options exercised (Restated)

 

13

 

Stock-based compensation

 

30

 

Shareholders’ equity balance at June 30, 2005 (Restated)

 

$

64,905

 

 

In May 2005, the Company purchased 11,614 common shares from an executive officer for $120, which represented 90% of the market value on the date of purchase.  There are currently no plans to repurchase additional shares.

 

Shareholder Rights Plan

 

On June 27, 2005, the Board adopted a Shareholder Rights Plan to protect shareholders from coercive or otherwise unfair takeover tactics and to protect the interests of the Company’s shareholders.  Pursuant to the Rights Agreement relating to the Shareholder Rights Plan, the Board has declared a dividend of one preferred share purchase right (a “Right”) for each share of common stock outstanding at the close of business on June 27, 2005.  In general terms, the Rights Agreement works by imposing a significant penalty upon any person or group that acquires 10% or more of the Company’s outstanding common stock without the approval of the Board.  The Company does not believe the Rights Agreement will interfere with any merger or other business combination approved by the Board.

 

Each Right will allow its holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock for $27.00 once the Rights become exercisable.  The Rights will not be exercisable until fifteen days after the public announcement that a person or group has become an “Acquiring Person” by obtaining beneficial ownership of 10% or more of the Company’s outstanding common stock, or, if earlier, fifteen business days after a person or group begins a tender or exchange offer which, if completed, would result in that person or group becoming an Acquiring Person.  If a person or group becomes an Acquiring Person, all holders of Rights except the Acquiring Person, may, for $27.00 purchase shares of the Company’s common stock with a market value of $54.00, based on the market price of the common stock prior to such acquisition.  In addition, if the Company is later acquired in a merger or similar transaction after the Rights have become exercisable and a person or group is, or becomes, an Acquiring Person, all holders of Rights except the Acquiring Person may, for $27.00, purchase shares of the acquiring corporation with a market value of $54.00 based on the market price of the acquiring corporation’s stock, prior to such merger.  The Board may redeem the Rights for $.0005 per Right at any time before any person or group becomes an Acquiring Person.

 

21



 

Note 13 – Significant Customer, Product Line and Geographic Information

 

The percentage of net revenues derived from major customers was as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

Net revenues:

 

 

 

 

 

 

 

 

 

Customer A

 

18

%

12

%

10

%

10

%

Customer B

 

 

*

20

%

 

*

11

%

Customer C

 

 

*

14

%

 

*

 

*

Customer D

 

 

*

11

%

 

*

 

*

Customer E

 

 

*

11

%

 

*

 

*

 

 

18

%

68

%

10

%

21

%

 


*                                         Customer represented less than 10% of net revenues during the period.

 

The percentage of net revenues by major product line was as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

Net revenues:

 

 

 

 

 

 

 

 

 

NSX Series

 

65

%

62

%

57

%

57

%

All Surface Systems

 

7

%

6

%

14

%

13

%

3Di Series

 

3

%

8

%

6

%

9

%

Other

 

25

%

24

%

23

%

21

%

 

 

100

%

100

%

100

%

100

%

 

All of the Company’s tangible long-lived assets are located in the United States, except for an insignificant amount of property and equipment in Taiwan and South Korea.  The Company derives revenues from shipments to customers outside of the United States.  The percentage of net revenues by the geographic region in which the customer is located was as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

Net revenues:

 

 

 

 

 

 

 

 

 

United States

 

13

%

32

%

17

%

30

%

Taiwan

 

45

%

50

%

48

%

36

%

South Korea

 

4

%

1

%

6

%

12

%

Europe

 

27

%

0

%

22

%

2

%

Japan

 

2

%

3

%

2

%

5

%

Rest of Asia

 

9

%

14

%

5

%

15

%

 

 

100

%

100

%

100

%

100

%

 

22



 

Note 14 – Recent Accounting Pronouncements 

 

In June 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 154, “Accounting Changes and Error Corrections—a replacement of APB No. 20 and FAS No. 3.”  SFAS 154 provides guidance on the accounting for and reporting of accounting changes and error corrections.  It establishes, unless impracticable, retrospective application as the required method for reporting a change in accounting principle in the absence of explicit transition requirements specific to the newly adopted accounting principle.  SFAS 154 also provides guidance for determining whether retrospective application of a change in accounting principle is impracticable and for reporting a change when retrospective application is impracticable.  The correction of an error in previously issued financial statements is not an accounting change.  However, the reporting of an error correction involves adjustments to previously issued financial statements similar to those generally applicable to reporting an accounting change retrospectively.  Therefore, the reporting of a correction of an error by restating previously issued financial statements is also addressed by SFAS 154.  SFAS 154 is required to be adopted in fiscal years beginning after December 15, 2005.  Adoption of SFAS No. 154 is not expected to have a material effect on the Company’s financial position, results of operations or cash flows.

 

In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations,” which is an interpretation of SFAS No. 143, “Accounting for Asset Retirement Obligations.”  The interpretation requires a liability for the fair value of a conditional asset retirement obligation be recognized if the fair value of the liability can be reasonably estimated.  The interpretation is effective no later than the end of fiscal years ending after December 15, 2005.  The interpretation is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

 

In December 2004, the FASB issued SFAS No. 123 (Revised 2004), “Share-Based Payment.”  SFAS No. 123R is a revision of SFAS No. 123, “Accounting for Stock-Based Compensation” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees” and its related implementation guidance.  SFAS No. 123R focuses primarily on accounting for transactions in which an entity obtains employee services through share-based payment transactions.  SFAS No. 123R requires a public entity to measure the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award at the date of grant.  The cost will be recognized over the period during which an employee is required to provide services in exchange for the award.  The SEC issued guidance in April 2005 announcing that public companies will be required to adopt SFAS No. 123R by their first fiscal year beginning after June 15, 2005.  While the Company cannot precisely determine the impact on net earnings as a result of the adoption of SFAS No. 123R, estimated compensation expense related to prior periods can be found in Note 4, “Stock-Based Compensation.”  The ultimate amount of increased compensation expense will be dependent on whether the Company adopts SFAS No. 123R using the modified prospective or retrospective method, the number of option shares granted during the year, their timing and vesting period, and the method used to calculate the fair value of the awards, among other factors the Company is currently assessing.

 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs - an amendment of ARB No. 43, Chapter 4.”  SFAS No. 151 clarifies the accounting for abnormal amounts of idle facility expenses, freight, handling costs, and spoilage.  It also requires that allocation of fixed production overheads to inventory be based on the normal capacity of production facilities.  SFAS No. 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005.  Adoption of SFAS No. 151 is not expected to have a material effect on the Company’s financial position, results of operations or cash flows.

 

23



 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Factors That May Affect Future Results

 

Certain statements made in this Form 10-Q/A, as well as oral statements made by us from time to time, which are prefaced with words such as “expects,” “anticipates,” “believes,” “projects,” “intends,” “plans” and similar words and other statements of similar sense, are forward-looking statements.  Our forward-looking statements generally relate to our growth strategies, financial results, future financial projections, product development activities and sales efforts.  Our actual results could differ materially from those projected in the forward-looking statements as a result of a number of factors, including but not limited to market acceptance of our products, our ability to successfully develop new products, our ability to protect our intellectual property, our dependence upon international customers and suppliers, our dependence on a small number of customers that account for a significant portion of revenues, availability of products from our suppliers, cyclicality in the microelectronic manufacturing equipment and other industries, management of growth, integration of acquired businesses, and the other risk factors detailed below and in our Amendment No. 1 on Form 10-K/A for the year ended December 31, 2004, which is being filed with the SEC concurrently with this Form 10-Q/A.  We disclaim any obligation to revise forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.  Because many factors are unforeseeable, the foregoing should not be considered an exhaustive list.

 

Introduction

 

The following discussion of our results of operations and financial condition should be read together with the other financial information and consolidated financial statements and related notes included in this Form 10-Q/A.  All applicable disclosures in the following discussion have been modified to reflect the Restatement, as described below.  This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a variety of factors.

 

Restatement

 

We have restated our consolidated financial statements for the years 2004, 2003 and 2002 and for the first two quarters of 2005. Our restated consolidated financial statements also include disclosure of restated unaudited quarterly results for 2004 and 2003.  The initial determination to restate the 2004 and first half 2005 consolidated financial statements was made as a result of a correction of the Company’s application of revenue recognition principles, as contained in the Financial Accounting Standard Board’s Emerging Issues Task Force Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”).  As a result of subsequently reviewing our revenue recognition policies and procedures, we additionally noted that beginning in the fourth quarter of 2002 certain deferred software revenue should have been fully recognized upon delivery or customer acceptance rather than ratably over a twelve-month period. This created the need to restate our 2002 and 2003 consolidated financial statements.  Certain adjustments were recorded to each quarter in 2004 and first two quarters of 2005 to correct other miscellaneous items identified in prior external audits or quarterly reviews but were previously passed, none of which were individually significant.

 

In 2004 and the first half of 2005, the Company sold AXi 930 systems to a customer for an aggregate amount of approximately $12.2 million ($6.7 million in 2004, $3.1 million in the first quarter of 2005 and $2.4 million in the second quarter of 2005) and recognized the revenue for these sales.  The cost of revenues related to these sales was $2.7 million in 2004, $1.5 million in the first quarter of 2005 and $1.2 million in the second quarter of 2005.  For the three and six months ended June 30, 2004, the Company originally recognized $2.2 million in revenue and $0.9 million in cost of revenue for these AXi 930 sales.  During the same time periods, the Company accepted orders from the same customer for

 

24



 

enhancement packages to the AXi 930 system but had not yet delivered the enhancement packages.  In connection with preparing to finalize its results for the quarter ended September 30, 2005, the Company determined that recognition of the $12.2 million of revenue from the AXi 930 systems should have been deferred until the delivery of the enhancement packages, according to EITF 00-21.  The customer cancelled its orders for the enhancement packages on September 27, 2005, which allowed the Company to recognize the entire $12.2 million of AXi 930 deferred revenue in the quarter ended September 30, 2005.

 

In the fourth quarter of 2002, the Company began deferring Yield Pilot software revenue and recognizing it over a twelve-month period which represented the Company’s obligation to provide warranty and support.  The Company determined based on a subsequent review of Statement of Position 97-2, “Software Revenue Recognition” that Yield Pilot software revenues should have been recognized upon delivery or customer acceptance.  The correction of this error had no significant impact on revenues for the three months ended June 30, 2005 and decreased revenue by $0.3 million for the three months ended March 31, 2005.  The correction increased revenue by $0.4 million for each of the first two quarters in 2004 and had no impact on cost of revenues.  The correction increased revenue by $0.9 million, $0.5 million and $0.2 million for 2004, 2003 and 2002, respectively and had no impact on costs of revenues.

 

In the second quarter of 2005, the Company recognized $0.6 million in revenue and $0.2 million in cost of revenue related to the sale of an NSX 105 inspection system.  It was subsequently determined that this revenue should have been deferred until the newly introduced software component of this bundled transaction was completed and delivered.  This error was corrected as part of the restatement of the second quarter of 2005.  The Company expects to realize revenue on the completed transaction in the fourth quarter of 2005 when all elements will be delivered and accepted and fair value has been established for the newly introduced software component.

 

The Audit Committee worked closely with the Company’s management to review the Restatement and the Company’s policies and practices for the recognition of revenue.

 

The Restatement impacted the timing of revenue recognition as the AXi 930 enhancement packages have been deferred into the third quarter of 2005 and the Yield Pilot software revenue is recognized upon delivery or customer acceptance rather than ratably over a twelve-month period.  The impact of the Restatement on the consolidated statements of operations for the three-month and six-month periods ended June 30, 2005 and 2004 is shown in Note 2 to our consolidated financial statements included in this Form 10-Q/A.

 

The primary impact of the Restatement on the consolidated balance sheet at June 30, 2005 was to increase inventory at customers under purchase orders related to the deferral of the cost of revenue and to increase customer deposits and deferred revenues related to cash collected for revenue deferred in the Restatement.  The Restatement had no impact on cash balances or net cash flows from operating, investing, or financing activities.  The impact of the Restatement on the consolidated balance sheet and consolidated statements of cash flows is shown in Note 2 to our consolidated financial statements included in this Form 10-Q/A.

 

Critical Accounting Policies

 

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  We based these estimates and assumptions on historical experience and evaluate them on an on-going basis to help ensure they remain reasonable under current conditions.  Actual results could differ from those estimates. We discuss the development and selection of the critical accounting estimates with the audit committee of our board of directors on a quarterly basis, and the audit committee has reviewed our critical accounting policies as described in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Amendement No. 1 on Form 10-K/A for the year ended December 31, 2004.   For the six months ended June 30, 2005, there were no changes to these critical accounting policies.

 

25



 

Overview

 

We are a world-class provider of automated defect detection and product characterization systems for microelectronic device manufacturers.  Our systems provide manufacturers with information that enables process-enhancing decisions, ultimately lowering manufacturing costs and decreasing time-to-market.  We have traditionally provided systems to address the automated inspection needs of the early stages of the final manufacturing or back-end of the microelectronic device manufacturing process.  These needs were met primarily with our NSX Series and 3Di Series of products.  We have introduced the AXi Series and the E20 for edge and B20 for backside inspection systems (collectively, the “All Surface Inspection System”) for advanced macro defect detection primarily in the front-end of the wafer manufacturing process.  When used in conjunction with one another these systems allow a manufacturer to inspect the top, edge and back of a wafer’s surface.  We believe we are the first to offer all surface wafer inspection.  We continued to support front-end system demonstrations at many large semiconductor manufacturers during the quarter.  These demonstrations allow these customers to evaluate the benefits these systems provide.  We expect these demonstrations will lead to increased revenues six to nine months after shipment.

 

We complement this broad inspection capability with an expanding suite of software tools designed to enhance the speed and effectiveness of the process by which device manufacturers analyze defects, and make decisions regarding their manufacturing process to reduce or eliminate such defects.  We refer to this process as the “detection-to-decision” process.

 

Our business has been, and will continue to be, subject to the highly cyclical nature of the microelectronic device manufacturing markets we serve.  These cycles are caused by significant, and often rapid, fluctuations in the supply and demand of microelectronic devices driven by such factors as changes in technology and global economic conditions.  As a result of these fluctuations, and due to the fact that our quarterly revenues are comprised of systems with selling prices of between $150,000 and $1,000,000, a small change in the number of systems we sell may also cause significant changes in our operating results.  Because fluctuations in the timing of orders from our major customers or in the number of individual systems we sell could cause our revenues to fluctuate significantly in any given quarter or year, we do not believe that period-to-period comparisons of our financial results are necessarily meaningful, and they should not be relied upon as an indication of our future performance.  Additionally, the rate and timing of customer orders may vary significantly from month to month.  Accordingly, if sales of our products do not occur when we expect, and we are unable to adjust our estimates on a timely basis, our expenses and inventory levels may increase relative to revenues and total assets.

 

We have sold our systems to many of the leading microelectronic device manufacturers throughout the world.  Historically, a significant portion of our revenues in each quarter and year has been derived from sales to relatively few customers, and we expect this trend to continue.   In the six months ended June 30, 2005 and 2004 sales to customers that individually represented at least ten percent of our revenues accounted for 10% and 21% of our net revenues, respectively.

 

Management focuses on several key financial metrics in evaluating our financial condition and operating performance.  Although we do not believe backlog is always an accurate indication of future revenues and performance, since only a portion of our revenues for any quarter include systems that were in backlog as of the beginning of that quarter, we do closely monitor the level of orders both geographically and by product line and in relation to the level of revenues, referred to as the book-to-bill ratio.  During the second quarter of 2005, our book-to-bill ratio was above parity.  A book-to-bill ratio above parity indicates an increasing level of backlog.  In addition to monitoring our level of orders and backlog, we focus on revenues by product family compared to prior-period and current-year plans, year-over-year revenue growth compared to the overall semiconductor

 

26



 

equipment industry, operating profit or loss performance compared with prior-period and current-year plans and the level of operating cash flow.

 

Merger Activities

 

On January 21, 2005, we entered into an Agreement and Plan of Merger and Reorganization (the “Nanometrics Merger Agreement”) with Nanometrics, Incorporated (“Nanometrics”), Major League Merger Corporation and Minor League Merger Corporation.    Under the terms of the Nanometrics Merger Agreement each share of our common stock was to be converted into the right to receive 0.6401 of a share of August Nanometrics common stock.  On June 27, 2005, we and Nanometrics terminated the Nanometrics Merger Agreement.  In accordance with the terms of the Nanometrics Merger Agreement, we paid Nanometrics a termination fee of $8,300, and reimbursed $2,600 of merger related expenses.

 

On June 27, 2005, we entered into an Agreement and Plan of Merger (the “Rudolph Merger Agreement”) with Rudolph Technologies, Inc. (“Rudolph”) and NS Merger Sub, Inc.  Under the terms of the Rudolph Merger Agreement each of our shareholders will have the option to elect to receive either $10.50 per share in cash or 0.7625 of a share of Rudolph common stock, subject to proration and allocation, based on the total cash and shares available in the merger.  The agreement requires that the total consideration for the transaction will include a minimum of $37,200 and a maximum of $60,000 of cash subject to shareholder election.  The aggregate consideration was approximately $193,000 as of June 27, 2005.

 

On February 9, 2005, we received a letter from Kenneth Schroeder, President and Chief Executive Officer of KLA-Tencor Corporation (“KLA”), regarding KLA’s interest in pursuing a merger with us.  The letter stated that KLA proposed to acquire us in a transaction in which our shareholders would receive $11.50 per share.  KLA also stated that it would be willing to consider using stock as consideration.  Since the February 9 letter, KLA has made various public statements and additional communications to us (including a press release issued on July 13, 2005) stating that KLA continues to be interested in acquiring August Technology.  As of the date of this filing, KLA has been unwilling to execute a confidentiality agreement in a form acceptable to us and we have had no discussions with KLA regarding their proposal.

 

Results of Operations

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

(Restated)

 

(Restated)

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

100.0

%

100.0

%

100.0

%

100.0

%

Cost of revenues

 

41.5

 

45.3

 

43.3

 

43.6

 

Gross profit

 

58.5

 

54.7

 

56.7

 

56.4

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

43.2

 

29.9

 

42.7

 

30.3

 

Research and development expenses

 

19.8

 

18.4

 

22.0

 

17.9

 

Operating income (loss)

 

(4.5

)

6.4

 

(8.0

)

8.2

 

 

 

 

 

 

 

 

 

 

 

Merger expenses

 

(71.6

)

 

(41.6

)

 

Interest income

 

2.0

 

1.0

 

2.0

 

1.1

 

Net income (loss) before provision for income taxes

 

(74.1

)

7.4

 

(47.6

)

9.3

 

Provision for income taxes

 

0.3

 

0.3

 

0.3

 

0.3

 

Net income (loss)

 

(74.4

)%

7.1

%

(47.9

)%

9.0

%

 

Three and six months ended June 30, 2005 compared to the three and six months ended June 30, 2004

 

Net Revenues.  Net revenues decreased $1.3 million, or 7.1%, to $16.7 million for the three months ended June 30, 2005, from $18.0 million for the same period in 2004.  Net revenues decreased $3.1 million, or

 

27



 

8.8%, to $31.8 million for the six months ended June 30, 2005, from $34.9 million for the same period in 2004.  The decrease in net revenues during the six months ended June 30, 2005 was primarily due to a decrease in sales to the NSX/3Di and AXi series system sales partially offset by the revenues from DMS Vision which was acquired in July 2004.  Revenues derived from systems sold for front-end wafer fab applications accounted for 31.7% and 49.0% of total net revenues in the first half of 2005 and the first half of 2004, respectively.  Revenues in the third quarter of 2005 are expected to range from flat to an increase of 10%, as compared to the second quarter of 2005.

 

Net revenues from international sales represented 87% and 68% of total net revenues for the three months ended June 30, 2005 and 2004, respectively.  International revenues during these periods were primarily the result of sales to Asia, which comprised 60% and 68% of total net revenues for the three months ended June 30, 2005 and 2004, respectively.  Sales to Europe for the three months ended June 30, 2005 represented the next highest concentration with 27% of net revenues, which is the highest three-month revenue ever from that continent.  Net revenues from international sales represented 83% and 70% of total net revenues for the six months ended June 30, 2005 and 2004, respectively, and were primarily the result of sales to Asia, which comprised 61% and 68% of total net revenues.

 

Gross Profit.  Gross profit as a percent of net revenues increased to 58.5% for the three months ended June 30, 2005, from 54.7% for the same period in 2004.  Gross profit as percentage of net revenues increased to 56.7% for the six months ended June 30, 2005, from 56.4% for the same period in 2004.  Gross profit percentage increased primarily as a result of revenues from DMSVision software sales and improved margins within the NSX Series, partially offset by higher rework costs related to certain systems and the recording of lower of cost or market adjustments related to certain component parts that became obsolete due to engineering design changes.  We expect to continue to experience pricing pressure primarily related to our inspection systems sold into final manufacturing applications as competitors have continued to enter this market.  The impact of these reductions in gross profit is expected to be offset by higher margin products sold into front end applications.  We expect future gross profit as a percentage of net revenues to be between 54% and 57%.

 

Selling, General and Administrative Expenses.  Selling, general and administrative (“SG&A”) expenses consist primarily of employee salaries and related benefits, depreciation and amortization, and travel expenses.  SG&A expenses were $7.2 million and $13.6 million for the three and six months ended June 30, 2005, compared to $5.4 million and $10.6 million for the same periods in 2004.  SG&A expenses as a percentage of net revenues were 43.2% and 42.7% for the three and six months ended June 30, 2005, compared to 29.9% and 30.3% of net revenues for the same periods in 2004.  The increase in expense dollars was primarily the result of severance costs, amortization of purchased technology resulting from the DMSVision acquisition and technology purchased from Excelerate, and expenses associated with both increased personnel and support costs associated with an increased number of demo systems.  We expect SG&A expense dollars to decrease in the third quarter of 2005, as compared to the second quarter of 2005, due to a reduction in severance expenses, partially offset by increased marketing costs related to tradeshows.

 

Research and Development Expenses.  Research and development (“R&D”) expenses consist primarily of employee salaries and related benefits for individuals engaged in the research, design and development of new products.  R&D expenses were $3.3 million and $7.0 million for the three and six months ended June 30, 2005, compared to $3.3 million and $6.2 million for the same periods in 2004.  R&D expenses as a percentage of net revenues were 19.8% and 22.0% for the three and six months ended June 30, 2005, compared to 18.4% and 17.9% for the same periods in 2004.  The increase in expense dollars during the six months ended June 30, 2005 was primarily due to employee compensation and related benefits associated with the hiring of additional staff to complete certain stages of development of the all surface inspection systems.  In addition, expenses increased due to the DMSVision acquisition completed in July 2004.  We currently anticipate that research and development expense dollars will increase in the third quarter of 2005 as we continue to expand our suite of software solutions.

 

28



 

Interest Income.  Interest income was $0.3 million and $0.6 million for the three and six months ended June 30, 2005, compared to $0.2 million and $0.4 million for the same periods in 2004.  The increase in interest income was primarily due to an increase in the rate of return on our investment balances.

 

Merger Expenses.  Merger expenses were $12.0 million and $13.2 million for the three and six months ended June 30, 2005, compared to none in 2004.  The merger expenses included a $10.9 million termination fee paid to Nanometrics for terminating the Nanometrics Merger Agreement, legal and investment banker fees incurred prior to terminating the proposed merger with Nanometrics, and legal and investment banker fees incurred in conjunction with the proposed merger with Rudolph Technologies, Inc.

 

Income Taxes.  We currently anticipate a pretax profit in 2005 for income tax purposes, as compared to a pretax loss under generally accepted accounting principles, due to the fact that the merger expenses are primarily nondeductible for income tax purposes.  In addition, as a result of historical operating losses and uncertainty as to the extent of profitability in future periods, we began to record a valuation allowance against our deferred tax assets in the second quarter of 2002 and continue to do so at June 30, 2005.  Statement of Financial Accounting Standards (“SFAS”) No. 109 “Accounting for Income Taxes,” requires the establishment of a valuation allowance to reflect the likelihood of the realization of deferred tax assets.  As of December 31, 2004, the valuation allowance was $9.3 million.  The above factors have resulted in the recording of a provision for income taxes for the three and six months ended June 30, 2005 and 2004, primarily to reflect foreign income taxes and federal alternative minimum taxes owed.

 

Liquidity and Capital Resources

 

At June 30, 2005, our principal sources of liquidity consisted of cash, cash equivalents and investments in marketable debt securities of $41.9 million, compared to $50.4 million at December 31, 2004, a decrease of $8.5 million.  The decrease was primarily due to $12.3 million in cash paid for merger expenses and an increase in accounts receivable, partially offset by increases in accounts payable and accrued compensation.  During the next twelve months, and beyond, we intend to utilize our current sources of liquidity to fund operations, specifically to enhance our position in the front-end wafer fabrication process.  We have no outstanding debt at June 30, 2005.  Our liquidity is affected by many factors, some of which are based on the normal ongoing operations of our business, the most significant of which includes the timing of the collection of receivables, the level of inventories, capital expenditures and acquisitions.

 

Accounts Receivable.  Accounts receivable increased $2.1 million from December 31, 2004 to June 30, 2005.  Our days sales outstanding (“DSO”) during the three months ended June 30, 2005 was 54 days.  This compares to a DSO of 53 days in the first quarter of 2005.  The increase in the DSO during the second quarter is primarily due to the timing of revenues during the quarter.  The increase in accounts receivable resulted in a use of cash during the six months ended June 30, 2005, as we have funded shipments for increased revenues prior to receiving payments from customers.  We believe our DSO will be between 50 and 65 days in future quarters.

 

Inventories. Inventories increased $1.3 million from December 31, 2004 to June 30, 2005.  The increase is primarily due to an increase in raw material to support an anticipated increase in revenues during the second half of 2005 and new product introductions.  This increase was partially offset by a decrease in finished goods due to the transfer of certain systems to property and equipment for internal use and sales to third parties.

 

Inventories at Customers under Purchase Orders.  Inventories at customers under purchase orders increased from $6.7 million at December 31, 2004 to $9.3 million at June 30, 2005.  We anticipate that a portion of this inventory will be recognized as revenue during 2005.  We anticipate that this inventory will increase as shipments of newly introduced products increase.

 

29



 

Capital Expenditures.  Our capital expenditures during the first six months of 2005 were $843,000, consisting primarily of the capitalization of finished goods that have been transferred to engineering for test and characterization, and to sales for customer application studies.  This equipment is expected to be utilized for these purposes for its estimated life, generally three years.  Our total capital expenditures, including the capitalization of finished goods for internal use, are expected to be between $3.0 million and $4.0 million in 2005, as we continue to expand the use of internal test and development equipment and facilities to meet customer demand and better serve our customers.

 

Our liquidity is also affected by factors beyond our control related to the uncertainties of global economies and the cyclical nature of the semiconductor and microelectronic industries.  Although liquidity requirements will fluctuate based on the timing and extent of all of these factors and others, management believes that existing cash and investment balances will be adequate to satisfy our existing liquidity requirements for at least the next twelve months.

 

Cash Flows

 

Net cash used in operating activities for the six months ended June 30, 2005 was $8.5 million, primarily due to $12.3 million in cash paid for merger expenses, an increase in accounts receivable, inventories, and inventories at customers under purchase orders, partially offset by increases in accounts payable, accrued compensation, and customer deposits and deferred revenues.  Excluding cash payments for merger expenses, cash generated from operating activities was $3.9 million for the six months ended June 30, 2005.  Net cash provided by investing activities was $12.2 million, primarily due to $13.3 million of net proceeds from maturities of marketable debt securities, partially offset by $1.0 million of additions to property and equipment, and other assets.  Net cash provided by financing activities was $1.0 million, primarily related to proceeds received from exercises of stock options.  We currently expect to generate cash from operating activities during the remainder of 2005.

 

Net cash used in operating activities for the six months ended June 30, 2004 was $10.7 million, which resulted primarily from increased accounts receivable and inventories partially offset by our net income and increased accounts payable, accrued compensation and customer deposits.  Net cash provided by investing activities was $308,000, primarily due to $2.9 million of net proceeds from sales of marketable securities and partially offset by $2.5 million for purchases of property and equipment.  Net cash provided by financing activities was $2.0 million from the proceeds received from issuances of common stock.

 

New Accounting Pronouncements

 

In June 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 154, “Accounting Changes and Error Corrections—a replacement of APB No. 20 and FAS No. 3.”  SFAS 154 provides guidance on the accounting for and reporting of accounting changes and error corrections.  It establishes, unless impracticable, retrospective application as the required method for reporting a change in accounting principle in the absence of explicit transition requirements specific to the newly adopted accounting principle. SFAS 154 also provides guidance for determining whether retrospective application of a change in accounting principle is impracticable and for reporting a change when retrospective application is impracticable.  The correction of an error in previously issued financial statements is not an accounting change.  However, the reporting of an error correction involves adjustments to previously issued financial statements similar to those generally applicable to reporting an accounting change retrospectively.  Therefore, the reporting of a correction of an error by restating previously issued financial statements is also addressed by SFAS 154.  SFAS 154 is required to be adopted in fiscal years beginning after

 

30



 

December 15, 2005.  Adoption of SFAS No. 154 is not expected to have a material effect on our financial position, results of operations or cash flows.

 

In March 2005, the FASB issued FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations,” which is an interpretation of SFAS No. 143, “Accounting for Asset Retirement Obligations.”  The interpretation requires a liability for the fair value of a conditional asset retirement obligation be recognized if the fair value of the liability can be reasonably estimated.  The interpretation is effective no later than the end of fiscal years ending after December 15, 2005.  The interpretation is not expected to have a material impact on our financial position, results of operations or cash flows.

 

In December 2004, the FASB issued SFAS No. 123 (Revised 2004), “Share-Based Payment.”  SFAS No. 123R is a revision of SFAS No. 123, “Accounting for Stock-Based Compensation” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees” and its related implementation guidance.  SFAS No. 123R focuses primarily on accounting for transactions in which an entity obtains employee services through share-based payment transactions.  SFAS No. 123R requires a public entity to measure the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award at the date of grant.  The cost will be recognized over the period during which an employee is required to provide services in exchange for the award.  The SEC issued guidance in April 2005 announcing that public companies will be required to adopt SFAS No. 123R by their first fiscal year beginning after June 15, 2005.  While we cannot precisely determine the impact on net earnings as a result of the adoption of SFAS No. 123R, estimated compensation expense related to prior periods can be found in Note 4, “Stock-Based Compensation.”  The ultimate amount of increased compensation expense will be dependent on whether we adopt SFAS No. 123R using the modified prospective or retrospective method, the number of option shares granted during the year, their timing and vesting period, and the method used to calculate the fair value of the awards, among other factors we are currently assessing.

 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs - an amendment of ARB No. 43, Chapter 4.”  SFAS No. 151 clarifies the accounting for abnormal amounts of idle facility expenses, freight, handling costs, and spoilage.  It also requires that allocation of fixed production overheads to inventory be based on the normal capacity of production facilities.  SFAS No. 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005.  Adoption of SFAS No. 151 is not expected to have a material effect on our financial position, results of operations or cash flows.

 

31



 

Item 3.                                   Quantitative and Qualitative Disclosures About Market Risk

 

Market Risk

 

We are exposed to market risk primarily from changes in interest rates and credit risk.  We do not have material exposure to market risk from fluctuations in foreign currency exchange rates because all sales are made in U.S. dollars.

 

Interest Rate Risk

 

We are exposed to interest rate risk primarily from investments in cash equivalents and short-term and long-term marketable debt securities (the “Investment Portfolio”).  The entire Investment Portfolio, classified as available-for-sale, is recorded on the balance sheet at fair market value with unrealized gains or losses excluded from earnings and included in “Accumulated other comprehensive income (loss)” until realized.  The entire Investment Portfolio is denominated in U.S. dollars.  We do not use derivative financial instruments in the Investment Portfolio.  Due to the short duration of our Investment Portfolio, an immediate 10 percent change in interest rates is not expected to have a material adverse effect on our near-term financial condition or results of operations.

 

Credit Risk

 

Financial instruments which potentially subject us to credit risk consist principally of securities in the Investment Portfolio and trade receivables.  We limit credit risk related to the Investment Portfolio by placing all investments with high quality credit issuers and limit the amount of investments with any one issuer.  As of June 30, 2005, 71.4% of the Investment Portfolio consisted of government securities and corporate bonds with maturities of one year or less.  We limit credit risk associated with trade receivables by performing ongoing credit evaluations and believe that there is no additional risk beyond amounts provided for collection losses to be inherent in trade receivables.

 

Item 4.                                   Controls and Procedures

 

Overview

 

As previously disclosed in a Current Report on Form 8-K which we filed on September 29, 2005 and as described in our Explanatory Note to this Form 10-Q/A and Note 2 to our accompanying consolidated financial statements, in connection with preparing to finalize our results for the quarter ended September 30, 2005, we determined that certain revenue recognized in 2004 and the first half of 2005 should have been deferred until later periods.  As a result of subsequently reviewing our revenue recognition policies and procedures, we additionally noted that beginning in the fourth quarter of 2002 certain deferred software revenue should have been fully recognized upon delivery or customer acceptance rather than ratably over a twelve-month period.  We also have determined that an internal control deficiency existed related to the knowledge and application of revenue recognition methods in accordance with U.S. generally accepted accounting principles.  Based on the impact of the aforementioned accounting errors, we determined to restate our financial statements as of December 31, 2004 and 2003 and for each of the years in the three-year period ended December 31, 2004, as well as interim financial statements for the quarters ended March 31, 2005 and June 30, 2005.  Our restated consolidated financial statements also include disclosure of restated unaudited quarterly results for 2004 and 2003.

 

Management has determined that the internal control deficiency that resulted in the aforementioned accounting errors is a material weakness, as defined by the Public Company Accounting Oversight Board’s Auditing Standard No. 2.  We have determined that the material weakness was that we did not maintain adequate controls and procedures to assure that multi-element arrangements and related software revenue components were accounted for in accordance with generally accepted accounting principles.  The Public Company Accounting Oversight Board has defined a material weakness as “a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a

 

32



 

material misstatement of the annual or interim financial statements will not be prevented or detected.” Management has reviewed the internal control deficiency with our Audit Committee, has discussed it with our independent registered public accounting firm, KPMG LLP, and has advised our Audit Committee that the deficiency is a material weakness in our internal control over financial reporting.

 

(a)   Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

The effectiveness of our or any system of disclosure controls and procedures is subject to certain limitations, including the exercise of judgment in designing, implementing and evaluating the controls and procedures, the assumptions used in identifying the likelihood of future events, and the inability to eliminate misconduct completely. As a result, there can be no assurance that our disclosure controls and procedures will detect all errors or fraud. By their nature, our, or any, system of disclosure controls and procedures can provide only reasonable assurance regarding management’s control objectives.

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, or the “Exchange Act”) as of June 30, 2005. At the time of the initial filing of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2005, on the basis of that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective, to give reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.

 

In light of the material weakness in internal control over financial reporting referenced above, our Chief Executive Officer and Chief Financial Officer now believe that our disclosure controls and procedures were not effective at a reasonable assurance level as of June 30, 2005.

 

In response to this material weakness, management performed additional analyses and other post-closing procedures to ensure our restated consolidated financial statements were prepared in accordance with generally accepted accounting principles. Accordingly, management, including our Chief Executive Officer and Chief Financial Officer, believes the restated consolidated financial statements included in this report and our Form 10-K/A fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented.

 

(b)                                  Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred in the second quarter of 2005 that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

 

During October 2005, we implemented the remedial measures outlined below to address the identified material weakness in connection with the preparation of our restated financial statements included in our Form 10-K/A for the year ended December 31, 2004.  We have recently dedicated additional resources to the review of our control processes and procedures surrounding revenue recognition.  Furthermore, we have been conducting a thorough review and evaluation of our internal controls over revenue recognition as part of our compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002.

 

In order to remediate the weakness in our internal control over financial reporting, management has implemented the following measures as of the date of filing of this report and our Form 10-K/A:

 

33



 

                  Enhanced our revenue recognition procedures by updating our contract evaluation criteria and decision process flowcharts.  These evaluation and process updates were developed as a result of performing a thorough review of applicable accounting literature related to revenue recognition, particularly EITF No. 00-21, “Accounting for Revenue Arrangements with Multiple Deliverables.”

 

                  Modified our revenue recognition procedures on software contracts requiring postcontract customer support in accordance with the guidelines of SOP 97-2, “Software Revenue Recognition” and subsequent interpretations.

 

                  Enhanced our revenue recognition procedures to assure vendor-specific objective evidence is obtained to establish fair value for undelivered software elements prior to recognizing revenue.

 

                  Implemented additional training for accounting personnel to enhance their understanding of the applicable revenue recognition principles.

 

                  Implemented additional training for our sales personnel to enhance communications of pertinent revenue information to our accounting department that would impact accounting for agreements containing multiple deliverables.

 

34



 

PART II – OTHER INFORMATION

 

Item 1.                                   Legal Proceedings

 

The Company and each of its directors, Jeff O’Dell, James Bernards, Roger Gower, Michael Wright and Linda Hall Whitman, were named as defendants in two separate lawsuits that purported to be class action claims on behalf of the Company’s shareholders.  The Company received a summons and complaint with respect to the first of these proceedings on February 4, 2005 and the second on February 14, 2005.  Both lawsuits were brought in Minnesota State Court and claimed that the directors had breached their fiduciary duties to the Company’s shareholders in connection with their actions in agreeing to the proposed merger with Nanometrics Incorporated.  The plaintiffs in both actions sought various forms of injunctive relief including an order enjoining the Company and its board of directors from consummating the merger with Nanometrics.

 

The two proceedings were consolidated and heard as one case.  On April 19, 2005, the Court issued a 30 day stay of all proceedings.  On April 27, 2005, the plaintiffs scheduled a hearing on a motion to amend the complaint.  The hearing was scheduled for June 9, 2005.  On May 10, 2005 the Court issued an order dismissing the complaint for asserting derivative claims without complying with the rules governing derivative actions.  Thereafter the Court removed the hearing from the calendar.

 

On July 18, 2005, a purported shareholder class action lawsuit asserting derivative claims was filed in Minnesota state court against the Company and the individual members of the board named above as well as Lynn J. Davis, who joined the board on March 30, 2005 (the “Board”).  The lawsuit claims the directors have breached their fiduciary duties to Company’s shareholders in connection with their actions in approving the merger agreement with Nanometrics, Inc. and subsequently terminating that merger agreement and entering into a new merger agreement with Rudolph Technologies, Inc.  The plaintiff seeks various forms of injunctive relief including an order enjoining the Company and the Board from consummating the proposed merger with Rudolph.

 

The plaintiff in the lawsuit filed on July 18, 2005 is Robert Etem, the owner of 4,200 shares of the Company’s common stock.  Mr. Etem was also a plaintiff in the lawsuit described above filed on February 14, 2005.

 

On July 14, 2005, the Company filed a patent infringement lawsuit against Camtek, Ltd. of Migdal Haemek, Israel.  The patent infringement lawsuit, filed in U.S. federal court in Minneapolis, alleges that Camtek’s line of inspection equipment sold under the “Falcon” trademark infringes on the Company’s U.S. patent no. 6,826,298.

 

35



 

Item 2.                                   Unregistered Sales of Equity Securities and Use of Proceeds

 

The following table sets forth the repurchase of stock by the Company in the second quarter:

 

Period

 

(a) Total
Number of
Shares
Purchased

 

(b) Average
Price Paid per
Share

 

(c) Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs

 

(d) Maximum Number (or
Approximate Dollar
Value) of Shares that May
Yet be Purchased Under
the Plans or Programs

 

May 19, 2005

 

11,614

(1)

$

10.332

 

0

 

0

 

 

(1)                  Pursuant to a Redemption Agreement between the Company and Michael Plisinski, Vice President of Engineering, the Company repurchased the shares at a price equal to 90% of the closing price of the Company’s stock on the day preceding the repurchase date.  There is no agreement to repurchase additional shares.

 

Item 4.                                   Submission of Matters to a Vote of Security Holders

 

The Company held its Annual Meeting of Shareholders on May 25, 2005 at the Company’s world headquarters at 4900 West 78th Street, Bloomington, Minnesota.  Of the 17,970,496 shares of Common Stock outstanding as of April 13, 2005 (the record date), 16,476,676 (92%) were present or represented by proxy at the meeting.

 

1.                 The shareholders approved the Board of Director’s recommendation for setting the number of directorships at six.  This proposal received 14,704,125 votes for and 867,318 votes against, with 905,233 votes abstaining.

 

2.                 The shareholders elected Lynn J. Davis and Linda Hall Whitman as Class II Directors, pursuant to the following votes:

 

 

 

Votes For

 

Votes Withheld

 

Lynn J. Davis

 

14,604,115

 

1,872,561

 

Linda Hall Whitman

 

14,283,713

 

2,192,963

 

 

James A. Bernards and Roger E. Gower as Class III directors and Jeff O’Dell and Michael Wright as a Class I directors of the Company were not subject to reelection at this meeting, and thus their terms continued after the meeting.

 

3.                 The shareholders ratified the appointment of KPMG LLP as the Company’s independent auditors for the 2005 fiscal year.  This proposal received 14,728,283 votes for and 834,143 votes against, with 914,250 votes abstaining.

 

Item 6.                                   Exhibits

 

The exhibits listed on the Exhibit Index are filed herewith.

 

36



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

AUGUST TECHNOLOGY CORPORATION

 

 

 

 

Date: November 9, 2005

By:

/s/ JEFF L. O’DELL

 

 

Jeff L. O’Dell

 

Chief Executive Officer

 

(Principal Executive Officer)

 

 

 

 

Date: November 9, 2005

By:

/s/ STANLEY D. PIEKOS

 

 

Stanley D. Piekos

 

Chief Financial Officer

 

(Principal Financial and Accounting Officer)

 

37



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

EXHIBIT INDEX TO FORM 10-Q/A

 

For the quarter ended:

 

Commission File No.: 000-30637

June 30, 2005

 

AUGUST TECHNOLOGY CORPORATION

 

Exhibit Number

 

Description

 

 

 

10.1*

 

Amendment to Employment Agreement between the Company and David Klenk, dated May 5, 2005

 

 

 

10.2*

 

Separation Agreement and Release between the Company and David Klenk, dated May 5, 2005

 

 

 

31.1**

 

Certification pursuant to Exchange Act Rules 13a-14(a) of the Chief Executive Officer

 

 

 

31.2**

 

Certification pursuant to Exchange Act Rules 13a-14(a) of the Chief Financial Officer

 

 

 

32.1**

 

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to the Sarbanes-Oxley Act of 2002

 


*                 Previously filed with the Original Filing

**          Filed herewith

 

38